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Abstract
Exposure to high concentrations of oxygen has previously been shown to cause growth arrest in A549 cells, a distal lung
epithelial cell line. We found that when A549 cells were exposed to 95% oxygen they underwent substantial growth inhibition.
This was associated with induction of p21Waf1=Cip1=Sdi1 protein and a decrease in cyclin B1 protein. Flow cytometry revealed
that A549 cells exposed to hyperoxia had a significant decrease in the percentage of cells in G1 and a modest but significant
increase in the percentage of cells in S phase and G2/M, consistent with cells entering S phase. A549 cells in room air and
hyperoxia were then treated with nocodazole, a mitotic inhibitor. Room air A549 cells treated with nocodazole showed a
marked increase in G2/M consistent with mitotic arrest. In contrast, hyperoxic treated cells had a modest but significant
decrease in G1 but only a minimal increase in G2/M consistent with partial G1/S arrest and growth inhibition in S phase. To
further investigate the role of p21Waf1=Cip1=Sdi1 as a checkpoint regulator during hyperoxic growth inhibition, HCT116 cells
with wild-type and null p21Waf1=Cip1=Sdi1 were exposed to hyperoxia. Both wild-type p21(+/+) cells and null p21(3/3) cells
underwent growth inhibition when exposed to hyperoxia. At 48 h the hyperoxic treated HCT116 p21(+/+) had a similar cell
cycle distribution as the hyperoxic treated HCT116 p21(3/3) cells, suggesting that p21Waf1=Cip1=Sdi1 may not be essential for
growth arrest during hyperoxia. These findings suggest that hyperoxia causes partial growth arrest at different phases of the
cell cycle but primarily in S phase, that hyperoxic growth arrest is associated with a decrease in cyclin B1 protein and that p21
induction may not be essential for hyperoxic growth arrest. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
High concentrations of oxygen are frequently giv-
en for therapeutic reasons to maintain adequate tis-
sue oxygenation in children and adults who are se-
verely ill. Exposure to hyperoxia can result in the
release of free oxygen radicals within the cell [1].
An increase in free oxygen radicals can cause signi¢-
cant oxidative stress to the cell leading to profound
alterations in cell cycle regulation, growth arrest, cell
damage, and death [2]. Many genes induced during
hyperoxia are also involved in cell cycle regulation
[3^8]. These include p53 and p21Waf1=Cip1=Sdi1 (p21),
genes that are involved in cell growth by acting as
G1/S and G2/M checkpoint regulators [9,10]. In the
absence of a functional p53 gene, organisms are
more susceptible to the development of neoplasms
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[11]. The role of p21 is less clear. p21 has been shown
to be involved in checkpoint regulation at G1/S, S
and G2/M phases of the cell cycle but can also pro-
mote terminal di¡erentiation of cells independent of
p53 regulation [12,13]. Waldman et al. found that
cells de¢cient in p21 when damaged will undergo S
phase uncoupling with the development of polyploid
nuclei in the absence of mitosis [14]. Another study
found that when SAOS-2 cells were co-transfected
with p21, progression of the cell through S phase
was substantially reduced [15], suggesting that p21
is essential for normal S phase transition in the cell
cycle.
Recently it was shown that high oxygen concen-
tration induced S phase growth arrest in human
bronchial smooth muscle cells in association with
an induction in p21 and p53 protein levels [7]. In
our study we used A549 cells to determine the e¡ect
of high oxygen concentrations on cell growth and
cell cycle regulation. We found that exposure of
A549 cells to high oxygen concentrations causes a
partial growth arrest at G1/S, S and G2/M phases
of the cell cycle but primarily in S phase. Cyclin
B1, a cyclin necessary for cell mitosis, was signi¢-
cantly downregulated by 72 h while p21 was induced
after 24 and 48 h of hyperoxic exposure. The role of
p21 in hyperoxic growth arrest was further evaluated
using HCT116 p21(+/+) and p21(3/3) cells. Hyper-
oxia produced growth arrest and similar cell cycle
distributions in both p21(+/+) and p21(3/3) cells.
These ¢ndings suggest that hyperoxia inhibits epithe-
lial lung cell growth at more than one phase of the
cell cycle, but primarily in S phase, and that p21 may
not be an essential checkpoint regulator in cells ex-
posed to hyperoxia.
2. Methods
2.1. Cell lines
A549 cells were obtained from American Type
Culture Collection (ATTC, Rockville, MD). They
were grown to 50% con£uence in Ham’s F-12 me-
dium (Cellgro) with 10% fetal calf serum (FCS) and
penicillin/streptomycin (100 U/ml). Cells were grown
at least 2 days before being placed in hyperoxia.
Cells were placed in either a modular incubator
chamber (Billups-Rothenberg, del Mar, CA) and
gassed with 95% and 5% CO2 or placed in room
air and 5% CO2. HCT116 cells p21(+/+) and
p21(3/3) (a generous gift of B. Vogelstein) were
grown in McCoy’s 5A medium, 10% FCS and pen-
icillin/streptomycin (100 U/ml) and plated as above.
Cells were then harvested at speci¢c time periods for
cell counting, £ow cytometry and lysates for Western
blot analysis.
2.2. Western blots in cells
Whole cell lysates were solubilized in 2% SDS and
equally loaded per lane as determined using the Bio-
Rad DC protein assay kit (Bio-Rad, Hercules, CA).
Lysates were run on a 12% SDS-polyacrylamide gel
and transferred to nitrocellulose. Western blot anal-
ysis was performed using either an anti-p21 mono-
clonal antibody (65961A, Pharmingen, San Diego,
CA), cyclin B1 polyclonal antibody (1/200 dilution)
(sc-752, Santa Cruz), or anti-PCNA monoclonal
antibody (sc-56, Santa Cruz). The monoclonal anti-
bodies were used at concentrations of 1^2 Wg/ml as
recommended in 5% blotto, phosphate-bu¡ered sa-
line (PBS) and 0.05% Tween overnight at 4‡C. The
blots were washed three times in PBS-Tween, incu-
bated with a mouse Ig, horseradish peroxidase-linked
whole antibody (1/500 dilution) (RPN 2108, Amer-
sham, Arlington Heights, IL) or peroxidase-labeled
anti-rabbit antibody (1/2000 dilution) for 1 h then
washed and developed using chemiluminescence
(ECL) (RPN 2106; Amersham).
2.3. Flow cytometry
HCT116 cells and A549 cells were stained by in-
cubation in PBS containing 0.025% NP-40, propidi-
um iodide (100 Wg/ml) and ribonuclease (10 Wg/ml)
and placed on ice for 30 min. Cells were counted
using a FACScan (Becton Dickinson) and analyzed
with the program Mod Fit LT (Verity). To evaluate
checkpoint regulation, nocodazole, a mitotic inhibi-
tor, was added (0.4 Wg/ml) for 16 h to cells treated in
room air and hyperoxia.
2.4. Statistical analysis
Statistical calculations were performed using the
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SPSS 8.0 statistical package for Windows (Chicago,
IL). Di¡erences in measured variables between ex-
perimental and control groups were determined using
comparison of the means using a one-way ANOVA
and Student’s t-test (two-tailed, unequal variance).
Statistical di¡erence was accepted at P6 0.05.
3. Results
3.1. E¡ect of oxygen on cell growth and morphology
in A549 cells
At 48 h of 95% hyperoxia, the growth of A549
cells was signi¢cantly inhibited when compared to
A549 cells grown in room air (P6 0.01) (Fig. 1).
The morphology of cells in 95% oxygen also began
to change at 48 h with cells appearing more sparse,
elongated and with an increase in spindles when
compared to cells grown in room air (Fig. 2).
3.2. The e¡ect of oxygen on cell cycle pro¢le in
A549 cells
Flow cytometry was used to determine the e¡ect of
hyperoxia on the cell cycle. At 48 h of hyperoxia, the
cell cycle distribution of A549 cells underwent signif-
icant changes compared to room air cells. Hyperoxic
A549 cells had a signi¢cant decrease in percentage of
cells in G1 compared to room air cells (O2,
39.4 þ 6.9%; room air, 56.1 þ 6.5%, P6 0.0008).
This was associated with a modest but signi¢cant
increase in the percentage of cells in S phase (O2,
16.1 þ 2.3%; room air, 12.3 þ 2.1%, P6 0.002) and
G2/M (O2 22 þ 4.6%; room air, 14.7 þ 2.7%,
P6 0.001). These changes in cell cycle distribution
after 48 h of hyperoxia were more pronounced after
72 h of oxygen exposure (% G1 : O2, 39 þ 1.9%, room
air, 65 þ 5.0%, P6 0.0001; % S: O2, 15.4 þ 2.3%,
room air, 7.5 þ 0.9%, P6 0.0007; % G2/M: O2,
23.2 þ 2.2%, room air, 15.5 þ 1.6%, P6 0.0003) (Fig.
3).
To further clarify which phases of the cell cycle are
inhibited by hyperoxia, cells in room air and hyper-
oxia were then treated with nocodazole, a mitotic
inhibitor that blocks cells in mitosis. As expected,
room air A549 cells treated with nocodazole showed
a marked decrease in G1 (room air, 57.5 þ 9.1%,
room air+noc, 18.8 þ 17.1%, P6 0.004) and a
marked increase in G2/M (room air, 16.5 þ 3.1%,
room air+noc, 47.3 þ 10.9%, P6 0.002) (Fig. 4).
When hyperoxic exposed cells, however, were treated
with nocodazole they had a modest but signi¢cant
decrease in G1 (O2, 45 þ 4.7%, O2+noc, 36.1 þ 5.4%,
P6 0.02) but no signi¢cant increase in G2/M,
Fig. 1. Growth curve of A549 cells treated with 95% hyperoxia.
Cells were seeded at equal densities. At 2 days cells were either
placed in 95% hyperoxia and 5% CO2 or kept in room air and
5% CO2. Cells were counted at di¡erent time points up to 96
h. At 48, 72 and 96 h the hyperoxic treated cells were signi¢-
cantly less than the room air cells (*P6 0.01, **P6 0.007 and
***P6 0.02, respectively). For all groups at 24, 48 and 72,
n = 8; at the 96 h time point, n = 6. Error bars represent stan-
dard deviations.
Fig. 2. Cell morphology of A549 cells in 95% hyperoxia for 48
h. (a) A549 cells grown in room air and 5% CO2. (b) A549
cells grown in 95% O2 and 5% CO2 for 48 h.
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although an upward trend existed (O2, 20 þ 4.5%,
O2+noc, 26.1 þ 5.9%, P6 0.1).
These ¢ndings suggest that growth arrest in hyper-
oxic A549 cells is primarily occurring in S phase;
however, partial growth inhibition is also occurring
at G1/S and G2/M.
3.3. Protein levels of cyclin B1 and p21
We then measured cyclin B1 levels at di¡erent time
periods in hyperoxia. We found that by 72 h, cells
exposed to hyperoxia had a signi¢cant decrease in
cyclin B1 protein levels. p21 protein levels were
also measured and found to be increased in hyper-
Fig. 3. The e¡ect of 95% hyperoxia on the cell cycle of A549
cells at 48 and 72 h. (Top panel) Percentage of A549 cells in
G1, S and G2/M in room air and 95% oxygen for 48 h
(*P6 0.0008, **P6 0.002, ***P6 0.001). (Bottom panel) A549
cells after 72 h of either room air or 95% hyperoxia
(*P6 0.0001, **P6 0.0007, ***P6 0.0003). Comparisons of the
means were done by one-way ANOVA. Standard error bars
represent standard deviations. For the 48 h experiments, n = 9;
for the 72 h experiments, n = 5.
C
Fig. 4. Characterization of G1 and G2 checkpoints in A549
cells at 48 h. Cells were grown in either room air and 5% CO2
or 95% O2 and 5% CO2. At 24 h, nocodazole (0.4 Wg/ml) was
added for 16 h. Cells were then analyzed by £ow cytometry at
48 h. (A) Percentage of A549 cells in G1 and G2/M before and
after nocodazole treatment in room air and 95% hyperoxia. %
of cells in G1 in room air cells was signi¢cantly greater than in
room air+nocodazole, 95% hyperoxia and 95% hyperoxia+no-
codazole (*2VP6 0.004, P6 0.03 and P6 0.003 respectively). %
of cells in G1 in 95% hyperoxia alone was signi¢cantly greater
than in 95% hyperoxia+nocodazole (***P6 0.02). % of cells in
G2/M in room air+nocodazole was signi¢cantly greater than in
room air alone (**P6 0.002). Error bars represent standard de-
viations. n = 5 for each group. (B) Representative example of
cell cycle distribution of room air and hyperoxic treated cells
with and without nocodazole. On the x axis £uorescent inten-
sity of propidium iodide is a marker for DNA content.
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oxic treated cells. The increase in p21 protein was
found consistently at 24 and 48 h of hyperoxic ex-
posure. At 72 h, however, there was some variability
in p21 protein expression. A drop in p21 protein level
was seen in con£uent cells exposed to hyperoxia for
72 h; however, in non-con£uent cells p21 protein
levels remained elevated. Protein levels of proliferat-
ing cell nuclear antigen (PCNA) levels were un-
changed (Fig. 5).
3.4. HCT116 cells in hyperoxia
In order to study the role of p21 status during
hyperoxic growth inhibition, two lines of HCT116
cells, an adenocarcinoma cell line, were used. One
cell line contained wild-type p21(+/+) and the other
cell line was de¢cient in p21(3/3). Both p21(+/+)
and p21(3/3) cells underwent signi¢cant growth in-
hibition when exposed to 95% hyperoxia. Compared
to cells grown in room air they had signi¢cantly few-
er cells after 48 h (p21(+/+), P6 0.002; p21(3/3)
P6 0.02) and 72 h (p21(+/+), P6 0.001; p21(3/3),
P6 0.01) (Fig. 6).
We then compared the cell cycle distribution of
p21(3/3) and p21(+/+) cells grown in room air.
p21(3/3) cells had a decreased percentage of cells
in G1 (p213/3, 41.1 þ 2.4%; p21+/+, 58.3 þ 12.6%,
P6 0.01) and an increased percentage of cells in
G2/M (p213/3, 21.6 þ 2.4%; p21+/+, 14.2 þ 3.1%,
P6 0.0003) consistent with loss of G1/S checkpoint
regulation. This would be expected in cells de¢cient
in p21 protein (Fig. 7).
We next compared the cell cycle distribution of
p21(+/+) cells exposed to 48 h of hyperoxia with
p21(+/+) cells grown in room air. We found a de-
crease in G1 (34.9% vs. 58.4%, P6 0.002), an in-
crease in S phase (22.7% vs. 14.7%, P6 0.01) and
an increase in G2/M (19.3% vs. 14.2%, P6 0.01).
The HCT116 p21(+/+) cells in hyperoxia had a sim-
ilar cell cycle pro¢le as the A549 epithelial cells in
hyperoxia. The p21(3/3) cells exposed to 48 h of
hyperoxia also had a decrease in G1 compared to
p21(3/3) cells grown in room air (33.8% vs.
41.1%, P6 0.0004); however, no signi¢cant di¡er-
ence in the percentage of cells in S phase (22.3%
Fig. 5. p21, cyclin B1 and PCNA expression in A549 cells.
Equal amounts of whole cell lysates from A549 cells grown in
room air+5% CO2 or 95% O2+5% CO2 were loaded and run
on a 12% SDS-polyacrylamide gel. Western blot analysis using
an anti-p21Waf1=Cip1=Sdi1 monoclonal antibody (65961A, Phar-
mingen), cyclin B1 polyclonal antibody (sc-752, Santa Cruz),
and anti PCNA monoclonal antibody (sc-56, Santa Cruz) was
performed. (Top panel) Increased amounts of p21 protein and
decreased amounts of cyclin B1 protein were detected in cells
exposed to hyperoxia. No signi¢cant change in PCNA was
found. (Bottom panel) In cells exposed to hyperoxia at con£u-
ence a decrease in p21 protein was detected at 72 h.
Fig. 6. Growth curve of HCT116 p21(+/+) and p21(3/3) cells
in room air and in 95% hyperoxia. Cells were seeded at equal
densities. At 2 days, cells were either placed in 95% O2 and 5%
CO2 or kept in room air and 5% CO2. Cells were counted at
di¡erent time points up to 72 h. At 24 h the number of p21-
(+/+) cells in room air were signi¢cantly greater than the num-
ber of p21(3/3) cells in room air (*P6 0.04). At 48 and 72 h
the O2 treated cells were signi¢cantly less than the room air
cells in both p21(+/+) and p21(3/3) groups (48 h, p21(+/+)
room air and p21(+/+) O2, P6 0.002, p21(3/3) room air and
p21(3/3) O2, **P6 0.02; at 72 h, p21(+/+) room air and
p21(+/+) O2, P6 0.001, p21(3/3) room air and p21(3/3) O2,
***P6 0.01). For all groups at 24, 48 and 72 h, n = 10. Error
bars represent standard deviations.
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vs. 18.4%, P6 0.3) and G2/M (21.3% vs. 21.6%,
P6 0.9) was observed. There were no signi¢cant dif-
ferences found in the percentage of cells in G1, S and
G2/M between hyperoxic treated p21(+/+) and
hyperoxic treated p21(3/3) cells, suggesting that
p21 is not essential for growth inhibition during hy-
peroxic stress.
4. Discussion
The lung is particularly sensitive to oxidant injury
and when it is exposed to high oxygen concentrations
free oxygen radicals are released resulting in lung
injury and impaired growth [16,17]. In this study
we used A549 cells to determine the e¡ect of hyper-
Fig. 7. The e¡ect of 95% hyperoxia on the cell cycle distribution in HCT116 p21(+/+) and p21(3/3) cells at 48 h. (A) In p21(+/+)
room air cells, the percentage of cells in G1 was signi¢cantly greater than in p21(3/3) room air cells, p21(+/+) hyperoxic cells, and
p21(3/3) hyperoxic cells (*P6 0.01, 2P6 0.002 and SP6 0.002, respectively). In p21(3/3) room air cells, the percentage of cells in
G1 was signi¢cantly greater than in p21(3/3) hyperoxic cells (VP6 0.0004). In p21(+/+) room air cells, the percentage of cells in
G2/M was signi¢cantly less than in p21(+/+) hyperoxic cells and p21(3/3) room air cells (***P6 0.01 and 3P6 0.0003, respectively).
In p21(+/+) room air cells, the percentage of cells in S phase was signi¢cantly less than in p21(+/+) hyperoxic cells (**P6 0.01). Com-
parisons of the means were done by one-way ANOVA. Standard error bars represent standard deviations, n = 7. (B) Representative
cell cycle analysis of HCT116 cells in room air and hyperoxia. Note that the cell cycle pro¢les are similar in the two groups of hyper-
oxic treated cells.
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oxia on the cell cycle distribution of pulmonary ep-
ithelial cells. We found that a signi¢cant proportion
of A549 cells exposed to hyperoxia entered S phase
but underwent growth arrest prior to mitosis. Fur-
thermore, hyperoxic growth arrest in A549 cells was
associated with a decrease in cyclin B1 and an in-
crease in p21 protein.
Cyclin B1 is essential for the initiation of mitosis
with protein accumulation of cyclin B1 occurring
during S phase [18]. Prior to S phase cyclin B1 is
degraded through proteolysis through the interaction
of anaphase-promoting complex (APC) with its sub-
unit Cdh1 [19]. Cyclin B1 complexes with cdc2 and
activation of this complex allows mitosis to take
place [20]. E2F-dependent expression of cyclin A is
necessary for cyclin B1 accumulation during S phase.
This occurs when the cyclin A-Cdk2 complex phos-
phorylates Cdh1 inactivating the Cdh1-APC complex
[19]. It has been shown previously that NIH3T3 cells,
with a mutation in E2F, will exhibit delayed growth
and an increase in the percentage of cells in S phase
after 48 h of low serum conditions [21]. Both p21 and
14-3-3c have been shown to regulate cyclin B1 levels
in the cell. 14-3-3c has been shown to sequester the
cdc2-cyclin B1 complex in the cytoplasm while p21
inactivates cdc2-cyclin B1 complexes that are in the
nucleus [22]. We found a marked decrease in cyclin
B1 levels in A549 cells during hyperoxic exposure.
The cause of this decrease may be secondary to an
increase in ubiquination and proteolysis of cyclin B1
through the Cdh1-APC pathway. Furthermore an
increase in either p21 or 14-3-3c may inactivate the
cdc2-cyclin B1 complex causing growth arrest prior
to entry into mitosis.
Cell cycle distribution analysis of A549 cells, using
£ow cytometry, suggests that hyperoxia is inhibiting
growth of the cell at more than one phase of the cell
cycle. A decrease in G1 and an increase in S phase
are consistent with hyperoxia blocking A549 cells in
the S phase of the cell cycle. There was also a modest
but signi¢cant increase in G2/M. Furthermore, treat-
ment of hyperoxic cells with nocodazole resulted in a
decrease in G1 but not a signi¢cant increase in either
S phase or G2/M, suggesting that hyperoxia also
caused a partial G1/S arrest in the cell cycle.
We were interested in determining if the cyclin-de-
pendent kinase inhibitor p21 was necessary for hy-
peroxic induced growth inhibition. We found that
p21 protein was consistently increased in A549 cells
treated with 95% oxygen for 24 and 48 h. p21 is a
known checkpoint regulator of G1/S and has been
shown previously to block cdk2 kinase activity,
therefore preventing progression of the cell into mi-
tosis [23]. Blocking cdk2 inactivates the cdc2-cyclin
B1 complex in the nucleus, causing growth arrest
prior to mitosis. Therefore our ¢ndings that hyper-
oxia causes a partial G1/S and S phase growth arrest
would be consistent with p21 acting as a checkpoint
regulator during hyperoxia at two di¡erent phases of
the cell cycle. Interestingly we found that p21 protein
levels decreased at 72 h in A549 cells grown to con-
£uence. The cause of this decrease in p21 protein
levels is not clear. Bilodeau et al. also found that
p21 protein levels were decreased in T47D-H3 cells,
a p53 mutant cell line, after 64 h of 95% [24]. They
surmised that p21 is not involved in hyperoxic
growth inhibition and that the depletion of p21 pro-
tein is secondary to increase ubiquination and pro-
teolysis of p21 during hyperoxia.
We found in HCT116 cells that, regardless of p21
status, cells underwent growth inhibition during hy-
peroxia. In room air, when HCT116 cells de¢cient in
p21(3/3) were compared to p21(+/+) cells, they had
a smaller percentage of cells in G1 and a greater
percentage of cells in G2/M, consistent with a loss
of G1/S checkpoint regulation. Interestingly in hyper-
oxia, the cell cycle distributions of p21(+/+) and
p21(3/3) cells were not signi¢cantly di¡erent from
each other. There were no signi¢cant di¡erences be-
tween the two cell lines in percentage of cells in G1, S
and G2/M after 48 h hyperoxia. Therefore in both
the absence and presence of p21, HCT116 cells ex-
posed to hyperoxia undergo growth arrest and have
similar cell cycle pro¢les, suggesting that p21 induc-
tion is not essential for growth arrest during hyper-
oxia. Furthermore, A549 cells have a wild-type p21
gene and the partial G1/S growth arrest found in the
hyperoxic treated A549 cells may be secondary to a
functional p21 gene, acting as a checkpoint regulator
at G1/S and the S phase growth inhibition may be
occurring independent of p21.
Other genes that may be involved in hyperoxic
growth arrest include 14-3-3c and p53. 14-3-3c acts
by sequestering cdc2-cyclin B1 complexes in the cy-
toplasm, thus preventing the cell from entering mi-
tosis [22]. This gene may be involved in growth arrest
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during hyperoxia in the absence of p21. p53 may be
involved in hyperoxic growth arrest independent of
p21. In a study by Park et al., they found that p53
inhibited expression of cyclin B1 and cdc2 causing
inhibition of cdc2 kinase thus preventing the cell
from entering mitosis [25]. Others have found that
hyperoxia causes S phase growth arrest. Bjerkvig et
al., using endothelial cells, found an increased per-
centage of cells in S phase in cells exposed to 95%
hyperoxia for 24^48 h [26]. Shenberger et al. found
that 95% oxygen induced S phase arrest in human
bronchial smooth muscle cells and that this was as-
sociated with an increase in p21 and p53 levels [27].
In our study we found that hyperoxia causes
growth arrest by inhibiting more than one phase of
the cell cycle. A signi¢cant percentage of A549 cells
undergo growth arrest in S phase, although we also
found partial growth inhibition at G1/S and G2/M.
Hyperoxic growth arrest is associated with a decrease
in cyclin B1 protein levels and an increase in p21
protein. The role of p21 as a checkpoint regulator
during hyperoxia is not clear since HCT116 p21-
(3/3) cells undergo hyperoxic growth arrest with a
similar cell cycle distribution as the HCT116 p21-
(+/+) cells. This suggests that other cell cycle regu-
lators, such as 14-3-3c and p53, are involved in hy-
peroxic growth arrest. Additional studies will be
needed to further clarify the mechanisms involved
in cell cycle regulation during hyperoxic injury.
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